How to manage loculations in a patient with a suspected bacterial infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Loculations in Suspected Bacterial Infection

When loculations develop in a patient with suspected bacterial pleural infection, immediately flush the chest tube with 20-50 mL normal saline to restore patency, obtain imaging (ultrasound or CT) to identify undrained locules, and initiate intrapleural fibrinolytic therapy with streptokinase (250,000 IU twice daily for 3 days) or urokinase (100,000 IU once daily for 3 days) if drainage remains inadequate. 1, 2

Initial Assessment and Mechanical Management

Restore Tube Patency First

  • When chest tube drainage ceases or becomes inadequate, the first step is flushing with 20-50 mL normal saline to ensure the tube is not mechanically obstructed 1, 2, 3
  • Inspect for kinking at the skin level, particularly with smaller bore drains, which can be repositioned and redressed using commercial dressings designed to reduce kinking 1, 2
  • If the tube remains permanently blocked despite flushing, remove it and insert a new chest tube under image guidance 1

Imaging to Identify Loculations

  • Ultrasound is the preferred initial imaging modality, with 81-88% sensitivity and 83-96% specificity for detecting septations, significantly outperforming CT (71% sensitivity, 72% specificity) 1
  • Contrast-enhanced CT scanning provides superior anatomical detail for locule mapping, tube position verification, and identifying pleural thickening that may prevent lung re-expansion 1, 2
  • Ultrasound should guide all interventions in loculated collections to reduce complications and increase procedural success 1

Intrapleural Fibrinolytic Therapy

Evidence-Based Dosing Regimens

The British Thoracic Society recommends fibrinolytic therapy as it improves radiological outcomes in loculated pleural infections 1, 2:

  • Streptokinase: 250,000 IU twice daily for 3 days 1, 2
  • Urokinase: 100,000 IU once daily for 3 days 1, 2
  • Tissue plasminogen activator (TPA) can be used as an alternative, particularly in patients with prior streptokinase exposure 1

Critical Safety Considerations

  • Patients receiving intrapleural streptokinase must receive a streptokinase exposure card, as systemic antibody responses may neutralize future streptokinase administration 1, 2
  • For subsequent fibrinolytic indications, these patients should receive urokinase or TPA instead of streptokinase 1, 2
  • Monitor for immunological adverse events including fever and leukocytosis, which occur more commonly with streptokinase than urokinase 1

Limitations of Current Evidence

While fibrinolytic therapy improves radiological drainage and may reduce the need for surgery, it remains unclear whether it reduces mortality 1. A meta-analysis concluded insufficient evidence exists to support routine fibrinolytic use for all empyemas, suggesting selective application in patients failing adequate chest tube drainage 1, 4.

Alternative Drainage Strategy: Saline Irrigation

When fibrinolytic therapy or surgery is not suitable, saline irrigation (250 mL three times daily through the chest tube) represents a conditional alternative 3:

  • This approach may reduce the need for thoracic surgery based on moderate-quality evidence 3
  • Saline irrigation helps maintain tube patency and facilitates drainage of loculated collections 3
  • Never add gentamicin or other aminoglycosides to irrigation solution, as they have poor pleural penetration and are inactivated in acidic pleural fluid 3

Surgical Escalation

Indications for Early Surgical Consultation

Obtain surgical consultation when chest tube drainage, antibiotics, and fibrinolytics fail 2:

  • Persisting sepsis with persistent pleural collection despite adequate drainage and antibiotics 2
  • Organized empyema with thick pleural peel requiring formal thoracotomy and decortication 2
  • Multiple loculations positioned on the mediastinum that cannot be accessed percutaneously 1

Thoracoscopic Intervention

  • Medical or surgical thoracoscopy allows direct visualization and breakdown of septations under direct vision 1
  • In one series, 60% of malignant pleural effusions had septations at thoracoscopy, with 15% having extensive adhesions obstructing two-thirds of the thoracoscopic view 1

Clinical Pitfalls to Avoid

Common Errors in Management

  • Do not delay imaging when drainage ceases—residual loculations will not resolve with antibiotics alone and require mechanical or fibrinolytic intervention 1, 5
  • Do not use saline irrigation as first-line therapy—it is reserved for situations where fibrinolytics or surgery are contraindicated 3
  • Never clamp a bubbling chest drain—if a clamped drain causes breathlessness or chest pain, immediately unclamp it 2
  • Loculated effusions are associated with longer hospitalizations and more frequent need for tube thoracostomy compared to non-loculated effusions 5

Prognostic Indicators

  • The presence of loculations correlates with exudative pleural fluid chemistries and "extreme" biochemical values, though no radiologic finding is specific for empyema 5
  • Pleural thickening on contrast-enhanced CT represents a fibrinous peel that may prevent lung re-expansion despite adequate drainage, though this peel may resolve over several weeks without surgery 1
  • Light's criteria for tube thoracostomy are unreliable in patients with loculated parapneumonic effusions or those receiving prolonged antibiotic therapy prior to thoracentesis 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Loculated Empyema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Intrapleural Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intrapleural fibrinolytic therapy for pleural infection.

Pulmonary pharmacology & therapeutics, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.